I am very pro-research on general principle. The exception lies with “studies” (like this example) which measure only specific short-term endpoints that are inherently hard to measure & quantify.

Things like clinical & economic benefit & those associated “outcomes”.

Everyone has a different definition of “success” in these cases.  Also just because it doesn’t show something concrete in dollars & cents or in data points doesn’t mean it doesn’t have value.

Continue reading →